{'fraction_non_alphanumeric': 0.02072538860103627, 'fraction_numerical': 0.0, 'mean_word_length': 5.595121951219512, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Comparative evaluation of indigenous ELISAs for detection of anti-cysticercus IgG antibodies in serum from clinically and radiologically suspected cases of neurocysticercosis.

Neurocysticercosis (NCC) is an important but neglected tropical infectious disease, which is recently recognized as a global problem due to its potentiality for human-to-human transmission beyond tropics. The laboratory diagnosis of NCC is considered useful to confirm clinical and radiological diagnosis. However there is a lack of indigenous diagnostic method particularly in the tropical developing countries. Present study aimed to develop and evaluate indigenously developed anti-cysticercus IgG-ELISAs for possible diagnosis of NCC among patients presenting with seizures. Three indigenous antibody detection assays were developed employing three different antigenic preparations from T. solium metacestode larvae (viz., TsM-CF, TsM-CW and TsM-PS). The overall test results showed varying levels of IgG titers in response to the three antigenic preparations as compared with the standard commercially procured antibody-ELISA. Total soluble protein extract of protoscoleces or TsM-PS-Ag employed in the indigenously developed IgG ELISA is recommended to be used as a routine screening test for a confirmatory diagnosis of NCC and other forms of cysticercosis in humans.